Cure Tuberculosis Project

Speeches Shim

The Cure Tuberculosis Project works closely with the Kyrgyz government to ensure that TB services are both high-quality and accessible, even for the country’s most hard-to-reach citizens.
The Cure Tuberculosis Project works closely with the Kyrgyz government to ensure that TB services are both high-quality and accessible, even for the country’s most hard-to-reach citizens.

The USAID Cure Tuberculosis Project is an $18.5 million investment over five years that will assist the Kyrgyz government to diagnose, treat, and cure people with drug-resistant tuberculosis.

People at risk of tuberculosis (TB) are often among the hardest to reach, which can make it difficult for them to access health services. The Cure Tuberculosis Project works closely with the Kyrgyz government to ensure that TB services are both high-quality and accessible, even for the country’s most hard-to-reach citizens. As stigma and discrimination often prevent people from getting the services they need, the Cure Tuberculosis Project will work to reduce tuberculosis stigma and discrimination among health care providers and the general public. 

The Cure Tuberculosis Project focuses on strengthening systems, tools, resources, and human capacity to improve the Kyrgyz Republic’s TB response in compliance with the latest international recommendations. The project will also strengthen the Kyrgyz government’s efforts to design, manage, and monitor a system of high-quality TB services available at local health care facilities and to create conditions where healthcare services meet the needs of the people. 

The Cure Tuberculosis Project is implemented by JSI Research & Training Institute, Inc. (JSI) in partnership with University Research Co., LLC (URC), and close collaboration with the Kyrgyz Republic’s National Tuberculosis Program under the Ministry of Health and national partners. 

Duration: July 2019 – July 2024

Budget: $18,450,292

Implementing Partner: JSI Research & Training Institute, Inc. (JSI) in partnership with the University Research Co., LLC (URC)

Key Partners: Ministry of Health of the Kyrgyz Republic, National Tuberculosis Program (NTP), Mandatory Health Insurance Fund (MHIF)

Activity Locations: Countrywide

MAJOR FOCUS AREAS

  1. Increase Drug-Resistant TB Case Detection. Strengthen laboratory and diagnostic services and expand detection and contact-tracing capabilities in communities and health facilities.
  2. Cure More Patients of Drug-Resistant TB. Ensure that all patients receive the correct treatment regimen with high-quality drugs and ensure all patients complete their treatment as directed.
  3. Prevent Drug-Resistant TB Infections. Improve infection control in health facilities and laboratories and improve patient, provider, and at-risk people’s behaviors around preventing, detecting, and treating TB. 
  4. Improve the Enabling Environment. Improve TB-related policies, optimize financing for TB services, enhance the use of TB data for decision-making, and reduce stigma and discrimination.

IMPACT AND RESULTS

Increase Drug-Resistant TB Case Detection. Strengthen laboratory and diagnostic services and expand detection and contact-tracing capabilities in communities and health facilities.

  • The project helped improve diagnosis of TB by restructuring the laboratory network in Chui Oblast and implementing a quality management system in these labs to ensure the accuracy of test results. In addition, 48 health facilities nationwide now have access to an online information system that manages TB test results. The system has 202 users and over 72,000 TB test results.
  • Cure Tuberculosis conducts information campaigns in communities to raise awareness of TB and reduce stigma and discrimination against TB patients. These campaigns have reached more than 300,000 people.

Cure More Patients of Drug-Resistant TB. Ensure that all patients receive the correct treatment regimen with high-quality drugs and ensure all patients complete their treatment as directed.

  • Cure Tuberculosis works with TB facilities to improve the quality of treatment and drug management. 14 TB hospitals now keep their medical records in digital format; the system currently has data on 7,259 patients.
  • More than 450 TB patients received social support including food and hygiene packages, psychological counselling, cash, and community-based treatment. Many patients lose their income during the treatment period, so they need this support in order to continue treatment.

Prevent Drug-Resistant TB Infections. Improve infection control in health facilities and laboratories and improve patient, provider, and at-risk people’s behaviors around preventing, detecting, and treating TB.

  • In order to prevent further spread of infection, Cure Tuberculosis assessed infection control measures in six oblast-level TB centers and 18 primary health organizations and developed plans to improve infection control.
  • The project conducted a research study focused on what Kyrgyzstanis experience in relation to TB testing, treatment, and stigma and discrimination. The research included 547 people primarily from vulnerable groups. Based on this study the project developed a strategy to change behaviors to encourage testing and treatment and reduce stigma and discrimination. Cure Tuberculosis has already produced seven videos on different topics related to TB that are shared widely by Kyrgyz government and media outlets.

Improve the Enabling Environment. Improve TB-related policies, optimize financing for TB services, enhance the use of TB data for decision-making, and reduce stigma and discrimination.

  • Cure Tuberculosis is working with the government to improve policies in the field of TB treatment and prevention. The project helped to adopt 12 different regulatory documents, develop a plan to reform four oblast TB centers, and improve financing mechanisms for TB services. The project also trained 1,002 individuals on different aspects of TB control in order to improve capacity in managing TB services.

COVID-19

To support the Kyrgyz response to the COVID-19 epidemic, Cure Tuberculosis implemented a series of measures to mitigate the impact of COVID-19 and preserve essential TB services:

  • Assisted in re-purposing the National TB Center and the leading TB lab in the country – the National Reference Laboratory - for COVID-19 testing and treatment.
  • Drafted a policy on adjusting TB services under emergency conditions. For example, patients were allowed to take a 14-day supply of drugs home and use video-observed treatment without the need for daily trips to a medical facility.
  • Modified the Laboratory data management information system (LDMIS) developed for TB to include COVID-19 testing data. Currently, it is used to manage all information about COVID-19 testing in Kyrgyzstan (more than 400,000 entries). This system also includes an SMS notification system for patient COVID-19 test results.
  • Helped to disseminate important information on TB/COVID-19 through social media.

Last updated: May 07, 2021

Share This Page